Publication Strategy for a Large Pharmaceutical Company
Client:
A leading global pharmaceutical company needed to demonstrate the clinical and economic burden of enlarged prostate (EP) and how its established product provided value in the treatment of EP. Xcenda was retained to generate and communicate evidence to support this initiative while enhancing the product’s value proposition.
Challenge:
Managed care decision makers were unclear as to the value of treating EP. They also questioned the need to utilize the specific clinical mechanism that differentiated the client’s product as a management option for treating EP. This lack of clarity and the absence of a comprehensive value proposition affected the formulary acceptance of the product. As such, there was a need to generate credible scientific data demonstrating the value of using the product to treat EP and communicate these data within a timely fashion to managed care stakeholders.
Xcenda’s Action:
Using a multidisciplinary team of health economists, epidemiologists, and project managers, Xcenda collaborated with the client, urologists, and payers to uncover data that demonstrated the burden of EP as well as the value of treating patients using the specific mechanism employed in the client’s product vs other branded and generic products. Upon completion of these engagements, Xcenda created, implemented, and managed the publication strategy to communicate the client’s findings to managed care decision makers. Xcenda provided journal recommendations along with manuscript and poster development, submission, and revisions for publication.
Results:
By generating credible evidence, developing a robust publications strategy, and utilizing experienced medical writers and editors, Xcenda helped the client demonstrate its product’s value to managed care decision makers through 14 publications. The client’s results were published in peer-reviewed scientific journals including the American Journal of Managed Care, the Journal of Health Care Finance, and Current Medical Research Opinion.
